Issue Date: January 18, 2016 | Web Date: January 14, 2016
Cancer Is Focus Of Deals At JPMorgan Conference
Drug companies like to present their first deals of the year at the JPMorgan Healthcare Conference, and this year was no exception. As the annual gathering of biotech and big pharma executives kicked off in San Francisco last week, companies unveiled a flurry of acquisitions and collaborations, with an emphasis on oncology.
Tensha Therapeutics said it will be acquired by Roche for $115 million plus up to $420 million in milestone payments. Founded by James . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society